European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome–Update 2017 F Trautinger, J Eder, C Assaf, M Bagot, A Cozzio, R Dummer, R Gniadecki, ... European journal of cancer 77, 57-74, 2017 | 526 | 2017 |
Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial AB Kimball, F Kerdel, D Adams, U Mrowietz, JM Gelfand, R Gniadecki, ... Annals of internal medicine 157 (12), 846-855, 2012 | 516 | 2012 |
European consensus statement on phenotypes of pustular psoriasis AA Navarini, AD Burden, F Capon, U Mrowietz, L Puig, S Köks, K Kingo, ... Journal of the European Academy of Dermatology and Venereology 31 (11), 1792 …, 2017 | 442 | 2017 |
Melanoma diagnosis by Raman spectroscopy and neural networks: structure alterations in proteins and lipids in intact cancer tissue M Gniadecka, PA Philipsen, S Wessel, R Gniadecki, HC Wulf, ... Journal of investigative dermatology 122 (2), 443-449, 2004 | 435 | 2004 |
Cutaneous Lymphoma International Consortium study of outcome in advanced stages of mycosis fungoides and Sézary syndrome: effect of specific prognostic markers on survival and … JJ Scarisbrick, HM Prince, MH Vermeer, P Quaglino, S Horwitz, P Porcu, ... Journal of Clinical Oncology 33 (32), 3766, 2015 | 429 | 2015 |
Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D RG Erben, DW Soegiarto, K Weber, U Zeitz, M Lieberherr, R Gniadecki, ... Molecular endocrinology 16 (7), 1524-1537, 2002 | 353 | 2002 |
Comparison of long‐term drug survival and safety of biologic agents in patients with psoriasis vulgaris R Gniadecki, B Bang, LE Bryld, L Iversen, S Lasthein, L Skov British Journal of Dermatology 172 (1), 244-252, 2015 | 324 | 2015 |
Safety, efficacy and drug survival of biologics and biosimilars for moderate‐to‐severe plaque psoriasis A Egeberg, MB Ottosen, R Gniadecki, S Broesby‐Olsen, TN Dam, ... British Journal of Dermatology 178 (2), 509-519, 2018 | 302 | 2018 |
Skin aging and natural photoprotection HC Wulf, J Sandby-Møller, T Kobayasi, R Gniadecki Micron 35 (3), 185-191, 2004 | 300 | 2004 |
Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris R Gniadecki, K Kragballe, TN Dam, L Skov British Journal of Dermatology 164 (5), 1091-1096, 2011 | 295 | 2011 |
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL) U Ralfkiaer, PH Hagedorn, N Bangsgaard, MB Løvendorf, CB Ahler, ... Blood, The Journal of the American Society of Hematology 118 (22), 5891-5900, 2011 | 288 | 2011 |
Guidelines on the use of extracorporeal photopheresis R Knobler, G Berlin, P Calzavara‐Pinton, H Greinix, P Jaksch, L Laroche, ... Journal of the European Academy of Dermatology and Venereology 28, 1-37, 2014 | 254 | 2014 |
Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma YH Kim, M Duvic, E Obitz, R Gniadecki, L Iversen, A Österborg, ... Blood, The Journal of the American Society of Hematology 109 (11), 4655-4662, 2007 | 253 | 2007 |
Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti‐inflammatory drugs: a D anish real‐world cohort study O Ahlehoff, L Skov, G Gislason, J Lindhardsen, SL Kristensen, L Iversen, ... Journal of internal medicine 273 (2), 197-204, 2013 | 221 | 2013 |
Cardiovascular outcomes and systemic anti‐inflammatory drugs in patients with severe psoriasis: 5‐year follow‐up of a Danish nationwide cohort O Ahlehoff, L Skov, G Gislason, R Gniadecki, L Iversen, LE Bryld, ... Journal of the European Academy of Dermatology and Venereology 29 (6), 1128-1134, 2015 | 212 | 2015 |
The optimal use of bexarotene in cutaneous T‐cell lymphoma R Gniadecki, C Assaf, M Bagot, R Dummer, M Duvic, R Knobler, A Ranki, ... British Journal of Dermatology 157 (3), 433-440, 2007 | 195 | 2007 |
Ultrasound structure and digital image analysis of the subepidermal low echogenic band in aged human skin: diurnal changes and interindividual variability M Gniadecka, R Gniadecki, J Serup, J Søndergaard Journal of investigative dermatology 102 (3), 362-365, 1994 | 185 | 1994 |
Hydrogen peroxide is responsible for UVA-induced DNA damage measured by alkaline comet assay in HaCaT keratinocytes AB Petersen, R Gniadecki, J Vicanova, T Thorn, HC Wulf Journal of Photochemistry and Photobiology B: Biology 59 (1-3), 123-131, 2000 | 176 | 2000 |
Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study CC Zouboulis, MM Okun, EP Prens, R Gniadecki, PA Foley, C Lynde, ... Journal of the American Academy of Dermatology 80 (1), 60-69. e2, 2019 | 174 | 2019 |
Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis SA Grando, JC Bystryn, AI Chernyavsky, M Frušić‐Zlotkin, R Gniadecki, ... Experimental dermatology 18 (9), 764-770, 2009 | 167 | 2009 |